ACRIVON THERAPEUTICS, INC. COMMON STOCK reports a Return on Equity (ROE) of -80.90%.

What is ACRV's dividend yield?

ACRIVON THERAPEUTICS, INC. COMMON STOCK offers a dividend yield of 0.00%.

What is ACRV's Deepscope Quality Score?

Deepscope rates ACRV's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ACRV?

Deepscope's AI Timing Score for ACRV is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ACRV belong to?

ACRIVON THERAPEUTICS, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

ACRV (NASDAQ) Stock Analysis | ACRIVON THERAPEUTICS, INC. COMMON STOCK

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-04 | FS: 2026-03-31)

ACRV

ACRIVON THERAPEUTICS, INC. COMMON STOCK

US:NASDAQ STOCK Healthcare >> Biotechnology News 64

USD 1.55

0.04 (2.65%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-80.9%

ROE

-71.7%

ROA

0.00%

Div Yield

ACRIVON THERAPEUTICS, INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.55 Price 0.04 (2.65%) Day Change	NEWS SCORE: 64

ACRV, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	64
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.55
PBV / Sector	0.68 / 4.58 GREAT
Earning Per Share	-1.85

PE / Sector	N/A / 17.10
PEG or PE/Growth / Sector	N/A / 0.52
Average 1M Daily Value	0.78 M GREAT
Average 1W Daily Value	0.61 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 450.23
NPM Average (%) / Sector	N/A / -1,506.33
NPM Change Average (%) / Sector	N/A / 4,941.30
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-71.65 / 30.58
ROA Average (%) / Sector	-46.55 / -347.17
ROA Change Average (%) / Sector	56.60 / 5,125.52 GREAT
ROE (%) / Sector	-80.90 / -3.58
ROE Average (%) / Sector	-52.59 / 40.65
ROE Change Average (%) / Sector	61.61 / 2,109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.50
Dividend Change Average (%) / Sector	N/A / 5.02

Registration Details

Analyze Date	2026-06-05 09:12:37
Symbol	ACRV
Name	ACRIVON THERAPEUTICS, INC. COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	42.80 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	64.63 / 8,655.90

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 480 Arsenal Way, Watertown, MA, United States, 02472

Phone: 617 207 8979

Website: https://acrivon.com

Employees: 74

Sector: Healthcare >> Biotechnology

Description: Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. The company was incorporated in 2018 and is based in Watertown, Massachusetts.